DK3524609T3 - Fremgangsmåde til fremstilling af 3-phenyl-2,3,4,8,9,10-hexahydropyrano[2,3-f]chromenderivater, optiske isomerer deraf og mellemprodukter fra processen - Google Patents
Fremgangsmåde til fremstilling af 3-phenyl-2,3,4,8,9,10-hexahydropyrano[2,3-f]chromenderivater, optiske isomerer deraf og mellemprodukter fra processen Download PDFInfo
- Publication number
- DK3524609T3 DK3524609T3 DK17858666.5T DK17858666T DK3524609T3 DK 3524609 T3 DK3524609 T3 DK 3524609T3 DK 17858666 T DK17858666 T DK 17858666T DK 3524609 T3 DK3524609 T3 DK 3524609T3
- Authority
- DK
- Denmark
- Prior art keywords
- chromener
- hexahydropyrano
- phenyl
- derivatives
- procedure
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20160127805 | 2016-10-04 | ||
| PCT/KR2017/010679 WO2018066872A1 (ko) | 2016-10-04 | 2017-09-27 | 3-페닐-2,3,4,8,9,10-헥사히드로피라노[2,3-f]크로멘 유도체 및 이의 광학 이성질체 합성 방법 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3524609T3 true DK3524609T3 (da) | 2021-07-26 |
Family
ID=61831886
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK17858666.5T DK3524609T3 (da) | 2016-10-04 | 2017-09-27 | Fremgangsmåde til fremstilling af 3-phenyl-2,3,4,8,9,10-hexahydropyrano[2,3-f]chromenderivater, optiske isomerer deraf og mellemprodukter fra processen |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US10669282B2 (da) |
| EP (1) | EP3524609B1 (da) |
| JP (1) | JP6810275B2 (da) |
| KR (2) | KR20180037584A (da) |
| CN (1) | CN109863152B (da) |
| AR (1) | AR109735A1 (da) |
| AU (1) | AU2017338514B2 (da) |
| BR (1) | BR112019006736A8 (da) |
| CA (1) | CA3039326C (da) |
| DK (1) | DK3524609T3 (da) |
| ES (1) | ES2881000T3 (da) |
| HU (1) | HUE055701T2 (da) |
| IL (1) | IL265706B (da) |
| MX (1) | MX2019003818A (da) |
| PL (1) | PL3524609T3 (da) |
| PT (1) | PT3524609T (da) |
| TW (1) | TWI641610B (da) |
| WO (1) | WO2018066872A1 (da) |
| ZA (1) | ZA201902760B (da) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11201811796SA (en) | 2016-06-29 | 2019-02-27 | Glaceum Inc | Optically active pyranochromenyl phenol derivative and pharmaceutical composition comprising same |
| KR20180037584A (ko) * | 2016-10-04 | 2018-04-12 | 주식회사 글라세움 | 3-페닐-2,3,4,8,9,10-헥사히드로피라노[2,3-f]크로멘 유도체 및 이의 광학 이성질체 합성 방법 |
| TWI804600B (zh) * | 2018-04-03 | 2023-06-11 | 南韓商格雷森伍股份有限公司 | 3-苯基-2,8-二氫吡喃[2,3-ƒ]苯并哌喃衍生物的合成方法 |
| WO2020071818A1 (ko) * | 2018-10-02 | 2020-04-09 | 주식회사 글라세움 | 탄소 이중결합 함유 화합물의 비대칭 수소첨가 반응용 촉매 |
| KR20200038182A (ko) | 2018-10-02 | 2020-04-10 | 주식회사 글라세움 | 탄소 이중결합 함유 화합물의 비대칭 수소첨가 반응용 촉매 |
| KR20200105198A (ko) * | 2019-02-28 | 2020-09-07 | 주식회사 글라세움 | 신경계 질환의 예방 또는 치료용 약학적 조성물 |
| KR20210014521A (ko) | 2019-07-30 | 2021-02-09 | 주식회사 글라세움 | 2-((6-(히드록시메틸)크로멘-5-일)옥시)-1-페닐에타논 유도체의 합성 방법 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100565423B1 (ko) * | 2003-10-20 | 2006-03-30 | 빅 바이오 주식회사 | 이소플라반 유도체 또는 이소플라벤 유도체의 제조방법 |
| JP2006008604A (ja) * | 2004-06-25 | 2006-01-12 | Kuraray Co Ltd | イソフラバン誘導体の製造方法 |
| WO2007058480A1 (en) * | 2005-11-16 | 2007-05-24 | Md Bioalpha Co., Ltd. | Composition having effect on treatment and prevention of diseases syndrome treatment with glabridin |
| US8563599B2 (en) * | 2008-03-03 | 2013-10-22 | The United States Of America, Represented By The Secretary Of Agriculture | Methods for synthesizing glycinols, glyceollins I and II, compositions of selected intermediates, and therapeutic uses thereof |
| CN101555259B (zh) * | 2009-05-15 | 2012-06-27 | 中国科学院上海有机化学研究所 | 螺环骨架膦噁唑啉配体、合成方法及其在不对称氢化反应中的应用 |
| CN103030647B (zh) | 2013-01-16 | 2014-10-29 | 山东省分析测试中心 | 一种光甘草定的合成方法 |
| KR102344479B1 (ko) * | 2013-12-24 | 2021-12-29 | 주식회사 글라세움 | 피라노크로메닐페놀 유도체, 및 대사증후군 또는 염증 질환 치료용 약학 조성물 |
| SG11201811796SA (en) * | 2016-06-29 | 2019-02-27 | Glaceum Inc | Optically active pyranochromenyl phenol derivative and pharmaceutical composition comprising same |
| KR20180037584A (ko) * | 2016-10-04 | 2018-04-12 | 주식회사 글라세움 | 3-페닐-2,3,4,8,9,10-헥사히드로피라노[2,3-f]크로멘 유도체 및 이의 광학 이성질체 합성 방법 |
-
2017
- 2017-09-27 KR KR1020170124941A patent/KR20180037584A/ko active Application Filing
- 2017-09-27 PT PT178586665T patent/PT3524609T/pt unknown
- 2017-09-27 HU HUE17858666A patent/HUE055701T2/hu unknown
- 2017-09-27 AR ARP170102680A patent/AR109735A1/es unknown
- 2017-09-27 PL PL17858666T patent/PL3524609T3/pl unknown
- 2017-09-27 TW TW106133241A patent/TWI641610B/zh active
- 2017-09-27 CA CA3039326A patent/CA3039326C/en active Active
- 2017-09-27 CN CN201780061809.7A patent/CN109863152B/zh active Active
- 2017-09-27 BR BR112019006736A patent/BR112019006736A8/pt unknown
- 2017-09-27 US US16/339,288 patent/US10669282B2/en active Active
- 2017-09-27 EP EP17858666.5A patent/EP3524609B1/en active Active
- 2017-09-27 JP JP2019539721A patent/JP6810275B2/ja active Active
- 2017-09-27 AU AU2017338514A patent/AU2017338514B2/en active Active
- 2017-09-27 WO PCT/KR2017/010679 patent/WO2018066872A1/ko active Application Filing
- 2017-09-27 ES ES17858666T patent/ES2881000T3/es active Active
- 2017-09-27 MX MX2019003818A patent/MX2019003818A/es unknown
- 2017-09-27 DK DK17858666.5T patent/DK3524609T3/da active
-
2018
- 2018-08-09 KR KR1020180093292A patent/KR101893393B1/ko active IP Right Grant
-
2019
- 2019-03-28 IL IL265706A patent/IL265706B/en active IP Right Grant
- 2019-05-02 ZA ZA2019/02760A patent/ZA201902760B/en unknown
-
2020
- 2020-03-03 US US16/807,218 patent/US10947250B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| IL265706A (en) | 2019-05-30 |
| CA3039326A1 (en) | 2018-04-12 |
| MX2019003818A (es) | 2019-08-12 |
| TWI641610B (zh) | 2018-11-21 |
| ES2881000T3 (es) | 2021-11-26 |
| TW201813970A (zh) | 2018-04-16 |
| US20200048272A1 (en) | 2020-02-13 |
| PL3524609T3 (pl) | 2021-12-27 |
| AU2017338514A1 (en) | 2019-05-23 |
| BR112019006736A8 (pt) | 2022-08-23 |
| PT3524609T (pt) | 2021-07-15 |
| KR20180037584A (ko) | 2018-04-12 |
| BR112019006736A2 (da) | 2019-07-23 |
| KR20180091803A (ko) | 2018-08-16 |
| CA3039326C (en) | 2022-09-20 |
| US20200199142A1 (en) | 2020-06-25 |
| IL265706B (en) | 2021-06-30 |
| CN109863152A (zh) | 2019-06-07 |
| KR101893393B1 (ko) | 2018-08-30 |
| AU2017338514B2 (en) | 2020-05-14 |
| EP3524609A1 (en) | 2019-08-14 |
| JP6810275B2 (ja) | 2021-01-06 |
| US10669282B2 (en) | 2020-06-02 |
| HUE055701T2 (hu) | 2021-12-28 |
| AR109735A1 (es) | 2019-01-16 |
| NZ753171A (en) | 2021-05-28 |
| WO2018066872A1 (ko) | 2018-04-12 |
| US10947250B2 (en) | 2021-03-16 |
| EP3524609A4 (en) | 2020-04-08 |
| JP2019529577A (ja) | 2019-10-17 |
| ZA201902760B (en) | 2021-09-29 |
| EP3524609B1 (en) | 2021-05-26 |
| CN109863152B (zh) | 2021-12-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3312177T3 (da) | Tricyklisk derivatforbindelse, fremgangsmåde til at fremstille samme og farmaceutisk sammensætning omfattende samme | |
| DK3524609T3 (da) | Fremgangsmåde til fremstilling af 3-phenyl-2,3,4,8,9,10-hexahydropyrano[2,3-f]chromenderivater, optiske isomerer deraf og mellemprodukter fra processen | |
| DK3524600T3 (da) | Fremgangsmåder og mellemprodukter til fremstilling af hidtil ukendte substituerede 6,7-dihydro-5h-benzo[7]annulenforbindelser | |
| DK3717471T3 (da) | Nye forbindelser og lægemiddelsammensætninger heraf til behandling af sygdomme | |
| DK3889145T3 (da) | 8-cyano-5-piperidino-quinoliner som TLR7/8-antagonister og anvendelser deraf til behandling af immunsygdomme | |
| DK3383363T3 (da) | Topiske farmaceutiske formuleringer til behandling af inflammatorisk-relaterede tilstande | |
| DK3286181T3 (da) | Pyrazolforbindelser og fremgangsmåde til fremstilling og anvendelse af forbindelserne | |
| DK3475417T3 (da) | Sammensætninger og fremgangsmåder til fremstilling af benzylisoquinolin-alkaloider, morphinan-alkaloider, thebain og derivater deraf | |
| DK3393655T3 (da) | Fenfluramin-sammensætninger og fremgangsmåder til fremstilling af samme | |
| DK3606929T3 (da) | Beta-nicotinat-ester-nukleotider og fremgangsmåder til fremstilling af samme | |
| DK3325482T3 (da) | Fremgangsmåder til fremstilling af cytotoksiske benzodiazepinderivater | |
| DK3255042T3 (da) | Heterocyklisk forbindelse og farmaceutisk sammensætning omfattende samme | |
| DK3081263T3 (da) | Sammensætninger og redskaber til behandling af glaukom | |
| DK3265443T3 (da) | Pyrrolidincarboxamidderivater og fremgangsmåde til fremstilling og anvendelse af samme | |
| DK3578562T3 (da) | L-valinatamidbenzoxaborolderivater til behandling af parasitiske sygdomme | |
| EP3724162C0 (en) | INTERMEDIATES FOR OPTICALLY ACTIVE PIPERIDINE DERIVATIVES AND METHODS OF PREPARATION THEREOF | |
| DK3487859T3 (da) | Antimetastatiske 2h-selenopheno[3,2-h]chromener, syntese deraf, og fremgangsmåder til brug af samme midler | |
| DK3573948T3 (da) | Fremgangsmåder til fremstilling af cytotoksiske benzodiazepinderivater | |
| DK3452465T3 (da) | Substituerede 2,4-diaminoquinolinderivater til anvendelse til behandling af proliferative sygdomme | |
| DK3442944T3 (da) | Fremgangsmåde til fremstillingen af 4-aminoindanderivater og relaterede aminoindanamider | |
| DK3459954T3 (da) | Ny polymorf af triazolo-pyrazin-derivat og fremgangsmåde til fremstilling af samme | |
| DK3512518T3 (da) | Buprenophinformuleringer med langvarig frigivelse | |
| DK3404033T3 (da) | C-glukosidderivat med kondenseret phenylring eller farmaceutisk acceptabelt salt deraf, fremgangsmåde til fremstilling deraf og farmaceutisk sammensætning indeholdende dette | |
| DK3604303T3 (da) | Hidtil ukendt pyrrolopyridinderivat, fremgangsmåde til fremstilling heraf og anvendelse deraf | |
| DK3176164T3 (da) | Optisk isomer af 1,4-benzothiazepin-1-oxidderivat og farmaceutisk sammensætning fremstillet ved anvendelse deraf |